Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $3.55M invested in Bio-Rad Laboratories Class B in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
1.87% less ownership
Funds ownership: 2.45% → 0.58% (-1.9%)
22% less funds holding
Funds holding: 9 → 7 (-2)
75% less capital invested
Capital invested by funds: $14.1M → $3.55M (-$10.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FNYS
First New York Securities
New York
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$10.8M |
| 2 |
Barclays
London,
United Kingdom
|
-$1K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$915 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $2.69M | -$915 | -8 | -0% |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $784K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $61K | +$58.2K | +509 | New |
|
4
Invesco
Atlanta,
Georgia
| $12K | – | – | – |
|
|
BIT
5
BlackRock Institutional Trust
San Francisco,
California
| $5K | – | – | – |
|
|
FNYS
6
First New York Securities
New York
| $1.32K | +$1.26K | +11 | New |
|
|
TM
7
Tikvah Management
Charlotte,
North Carolina
| – | -$10.8M | -95,197 | Closed |
|
|
8
Barclays
London,
United Kingdom
| – | -$1K | -6 | Closed |
|
BIO.B Hedge Fund Activity: Q4 2014 in Review
7 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2014, worth a combined $3.55M — down 75% from $14.1M a quarter earlier.
Fund positioning in BIO.B was balanced in Q4 2014: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was First New York Securities, opening a new position worth an estimated $1.26K. The largest seller was Tikvah Management, exiting entirely with an estimated $10.8M sold.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2014, down from 9 in Q3 2014.
- Funds reported $3.55M of Bio-Rad Laboratories Class B stock for Q4 2014, down 75% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q4 2014 and 2 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2014 was First New York Securities, an estimated $1.26K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2014 was Tikvah Management, an estimated $10.8M sold.
Based on aggregated 13F filings for Q4 2014.